Tayfur Toptaş

17PUBLICATIONS
180CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursLiquid biopsiesHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 04, 2026
Real-World Treatment Patterns and Safety Outcomes of Targeted Therapies in a Single-Center Chronic Lymphocytic Leukemia Cohort.

|Dec 11, 2025
Determinants of Eligibility and Timing of Autologous Transplantation in Multiple Myeloma: The Role of R-MCI and Diagnostic Plasma Cell Burden.

Ozlem Candan, Arda Bayar, Narmin Naghizada

|Nov 13, 2025
The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia.

Ozlem Candan, Imren Tatli, Abdullah Bakisli

|Oct 29, 2025
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Unal Atas, Utku Iltar, Orhan Kemal Yucel

|Oct 16, 2025
Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group.

Emel Isleyen, Nurcan Alhan, Esra Terzi Demirsoy

|Mar 18, 2025
Second-line use of dasatinib and nilotinib in a real-world patient population with chronic phase chronic myeloid leukemia.

Tayfur Toptas, Derya Demirtas, Ahmet Mert Yanik

Pageof 3

Frequent Collaborators

6 joint publications

Volkan Karakuş

5 joint publications

Fahir Özkalemkaş

4 joint publications

Meltem Aylı

4 joint publications

Ahmet Kurşat Güneş